SAN FRANCISCO, Calif. – Oct. 22, 2026 – Eko Health, a leader in clinical AI for the early detection of heart and lung disease, today announced the FDA clearance and launch of CORE 300, a new AI enabled stethoscope that combines advanced digital capabilities with traditional analog listening in a single device. Priced in line with premium traditional stethoscopes, CORE 300 brings Eko’s award-winning digital technology to a much broader group of healthcare professionals.
CORE 300 delivers enhanced listening and clinical information in the moments that matter most, whether in a crowded emergency department, a loud pediatric clinic, or a rural skilled nursing facility hours from specialty care. With a twist of the chestpiece, clinicians can move instantly between familiar traditional listening and Eko’s advanced digital listening technology, with up to 35x amplification, active noise cancellation, and real-time heart rate displayed directly on the device. When connected to the Eko App and Eko's FDA-cleared AI for structural murmur detection, CORE 300 can also bring AI disease detection into the physical exam.